DOCU.NASDAQDocusign, INC

Form 4: DocuSign Chief Legal Officer Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


DocuSign's Chief Legal Officer, James P. Shaughnessy, sold a total of 7,500 shares of common stock on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • James P. Shaughnessy, the Chief Legal Officer of DocuSign, Inc., executed sales of company stock on January 2, 2025.
  • These transactions were conducted under a pre-established Rule 10b5-1 trading plan.
  • A total of 6,659 shares were sold at a weighted average price of $90.13, with individual prices ranging from $89.52 to $90.42.
  • An additional 841 shares were sold at a weighted average price of $90.53, with individual prices ranging from $90.52 to $90.55.
  • Following these sales, Mr. Shaughnessy directly owns 43,781 shares of DocuSign common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of insider trading under a pre-arranged plan, which is neither positive nor negative in itself. It's a neutral event.

Risks

  • Sales by company insiders, even under pre-arranged plans, can sometimes be perceived negatively by the market.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and these transactions are often pre-planned under Rule 10b5-1 to avoid accusations of trading on non-public information. This filing is a routine disclosure of such activity.

Comparison to Industry Standards

  • Sales by executives are common across the tech industry, especially when part of a pre-arranged trading plan.
  • Companies like Adobe, Salesforce, and Oracle also see regular insider transactions, which are typically disclosed via SEC filings.
  • The volume of shares sold by Mr. Shaughnessy is not unusual for an executive at his level.

Stakeholder Impact

  • The stock sales may have a minor impact on shareholder sentiment, but are unlikely to cause significant price fluctuations given the pre-planned nature of the transactions.

Key Dates

DateDescription
01/02/2025Date of the stock sales by James P. Shaughnessy.

Keywords

DocuSign, insider trading, Form 4, Rule 10b5-1, stock sale, James P. Shaughnessy, Chief Legal Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.